M. Frau

发表

Mapping a sex hormone-sensitive gene determining female resistance to liver carcinogenesis in a congenic F344.BN-Hcs4 rat.

D. Calvisi, M. Muroni, M. D. De Miglio, 2007, Cancer research.

Mapping a sex hormone-sensitive gene determining female resistance to liver carcinogenesis in a congenic F344.BN-Hcs4 rat.

D. Calvisi, M. Muroni, M. D. De Miglio, 2006, Cancer research.

Mapping a sex hormone-sensitive gene determining female resistance to liver carcinogenesis in a congenic F344.BN-Hcs4 rat.

D. Calvisi, M. Muroni, P. Virdis, 2006 .

Role of HSP90, CDC37, and CRM1 as modulators of P16INK4A activity in rat liver carcinogenesis and human liver cancer

S. Thorgeirsson, D. Calvisi, M. Muroni, 2005, Hepatology.

Deregulation of DNA-dependent protein kinase catalytic subunit contributes to human hepatocarcinogenesis development and has a putative prognostic value

M. Evert, F. Dombrowski, S. Ladu, 2013, British Journal of Cancer.

Activation of v‐Myb avian myeloblastosis viral oncogene homolog‐like2 (MYBL2)‐LIN9 complex contributes to human hepatocarcinogenesis and identifies a subset of hepatocellular carcinoma with mutant p53

D. Calvisi, M. Evert, S. Ladu, 2011, Hepatology.

Long-term dehydroepiandrosterone and 16alpha-fluoro-5-androsten-17-one administration enhances DNA synthesis and induces expression of c-fos and c-Ha-ras in a selected population of preneoplastic lesions in liver of diethylnitrosamine-initiated rats.

M. Muroni, M. D. De Miglio, L. Deiana, 2001, Carcinogenesis.

Role of transcriptional and posttranscriptional regulation of methionine adenosyltransferases in liver cancer progression

D. Calvisi, T. Ushijima, S. Yamashita, 2012, Hepatology.

SKP2 and CKS1 promote degradation of cell cycle regulators and are associated with hepatocellular carcinoma prognosis.

D. Calvisi, D. Lim, M. Muroni, 2009, Gastroenterology.

Frequent loss of heterozygosity at the Hcr1 (hepatocarcinogenesis resistance) locus on chromosome 10 in primary hepatocellular carcinomas from LFF1 rat strain

D. Calvisi, M. Muroni, M. D. De Miglio, 2001, Hepatology.

Chemopreventive N-(4-hydroxyphenyl)retinamide (fenretinide) targets deregulated NF-{kappa}B and Mat1A genes in the early stages of rat liver carcinogenesis.

D. Calvisi, F. Pastorino, C. Brignole, 2004, Carcinogenesis.

Ras‐driven proliferation and apoptosis signaling during rat liver carcinogenesis is under genetic control

D. Calvisi, M. Muroni, M. D. De Miglio, 2008, International journal of cancer.

Cell cycle deregulation in liver lesions of rats with and without genetic predisposition to hepatocarcinogenesis

D. Calvisi, M. Muroni, M. D. De Miglio, 2002, Hepatology.

Altered methionine metabolism and global DNA methylation in liver cancer: Relationship with genomic instability and prognosis

D. Calvisi, M. Muroni, M. D. De Miglio, 2007, International journal of cancer.

Prognostic Significance of iNOS in Hepatocellular Carcinoma

F. Feo, M. Frau, R. Pascale, 2010 .

Hepatocellular carcinoma as a complex polygenic disease. Interpretive analysis of recent developments on genetic predisposition.

D. Calvisi, M. Muroni, M. D. De Miglio, 2006, Biochimica et biophysica acta.

Down-regulation of c-myc and Cyclin D1 genes by antisense oligodeoxy nucleotides inhibits the expression of E2F1 and in vitro growth of HepG2 and Morris 5123 liver cancer cells.

M. Muroni, M. D. De Miglio, M. Simile, 2003, Carcinogenesis.

Mybl2 expression is under genetic control and contributes to determine a hepatocellular carcinoma susceptible phenotype.

D. Calvisi, S. Ladu, M. Tomasi, 2011, Journal of hepatology.

Interaction of major genes predisposing to hepatocellular carcinoma with genes encoding signal transduction pathways influences tumor phenotype and prognosis.

F. Feo, M. Frau, R. Pascale, 2008, World journal of gastroenterology.

Deregulation of signalling pathways in prognostic subtypes of hepatocellular carcinoma: novel insights from interspecies comparison.

D. Calvisi, M. Tomasi, F. Feo, 2012, Biochimica et biophysica acta.

Identification and chromosome mapping of loci predisposing to colorectal cancer that control Wnt/beta-catenin pathway and progression of early lesions in the rat.

D. Calvisi, M. Muroni, M. D. De Miglio, 2007, Carcinogenesis.

Aberrant iNOS signaling is under genetic control in rodent liver cancer and potentially prognostic for the human disease.

D. Calvisi, M. Muroni, M. D. De Miglio, 2008, Carcinogenesis.

Pleiotropic effects of methionine adenosyltransferases deregulation as determinants of liver cancer progression and prognosis.

F. Feo, M. Frau, R. Pascale, 2013, Journal of hepatology.

Phenotypic reversion of rat neoplastic liver nodules is under genetic control

D. Calvisi, M. Muroni, M. D. De Miglio, 2003, International journal of cancer.

Prognostic markers and putative therapeutic targets for hepatocellular carcinoma.

F. Biasi, F. Feo, M. Frau, 2010, Molecular aspects of medicine.

Forkhead box M1B is a determinant of rat susceptibility to hepatocarcinogenesis and sustains ERK activity in human HCC

D. Calvisi, M. Muroni, M. D. De Miglio, 2009, Gut.

New insights on the role of epigenetic alterations in hepatocellular carcinoma

C. Feo, F. Feo, M. Frau, 2014, Journal of hepatocellular carcinoma.

Polygenic control of hepatocarcinogenesis in Copenhagen × F344 rats

D. Calvisi, M. C. Archer, M. Muroni, 2004, International journal of cancer.

The degradation of cell cycle regulators by SKP2/CKS1 ubiquitin ligase is genetically controlled in rodent liver cancer and contributes to determine the susceptibility to the disease

D. Calvisi, M. Muroni, S. Ladu, 2009, International journal of cancer.

Chromosome mapping of multiple loci affecting the genetic predisposition to rat liver carcinogenesis.

D. Calvisi, M. Muroni, M. D. De Miglio, 2002, Cancer research.

Genetic and Epigenetic Control of Molecular Alterations in Hepatocellular Carcinoma

M. Tomasi, S. Brozzetti, F. Feo, 2009, Experimental biology and medicine.

Dual-specificity phosphatase 1 ubiquitination in extracellular signal-regulated kinase-mediated control of growth in human hepatocellular carcinoma.

D. Calvisi, M. Muroni, M. D. De Miglio, 2008, Cancer research.

New putative prognostic markers and therapeutic targets for the molecular approach to treatment of hepatocellular carcinoma

M. Simile, F. Feo, M. Frau, 2011 .

sustains ERK activity in human HCC susceptibility to hepatocarcinogenesis and Forkhead box M 1 B is a determinant of rat

M. Muroni, S. Ladu, F. Pinna, 2009 .

An expression signature of phenotypic resistance to hepatocellular carcinoma identified by cross-species gene expression analysis

Ju-Seog Lee, G. Solinas, M. Tomasi, 2012, Cellular Oncology.

The degradation of cell cycle regulators by SKP2/CKS1 ubiquitin ligase is genetically controlled in rodent liver cancer and contributes to determine the susceptibility to the disease

D. Calvisi, M. Muroni, S. Ladu, 2009, International Journal of Cancer.

D. Calvisi, M. Evert, S. Ladu, 2011, Hepatology.